CellMax Life Stock
CellMax Life is a biotechnology company that is focused on developments in early cancer detection and prevention.
Sign up today and learn more about CellMax Life Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About CellMax Life Stock
CellMax Life is a biotechnology company that is revolutionizing early cancer detection and prevention. The company’s product portfolio includes a blood test that can detect cancer before it is too late. CellMax Life was founded in 2013 and is based in California, United States. The company has offices in Silicon Valley (U.S.) and Taiwan, and is funded by a venture capital firm in the U.S. and technology industrialists in Taiwan.
Funding History
| June 2013 | $5.0M |
|---|---|
| July 2016 | $9.0M |
Management
Board Member
Amit Shah
Co-Founder
Ying-Chih Chang
Board Member
Akhil Saklecha
Co-Founder & CEO
Atul Sharan
Press
prweb - Aug, 4 2023
CellMax Life Appoints Dr. Ross D. “Rusty” Segan to Advisory Boardgenomeweb - Apr, 8 2023
People in the News at CellMax Life, Jackson Lab, BC Platforms, GeneDxnews-medical - Jul, 28 2018
Opinionprweb - Jun, 6 2018
CellMax Life’s Early Cancer Detection Platform Wins 2018 MedTech Breakthrough Awardprnewswire - May, 30 2018
CellMax Life Launches Zenith, a U.S. Clinical Study for the Advancement of Blood Tests for Early Cancer Detection, With the Goal of Seeking FDA Approvalprweb - Apr, 10 2018
CellMax Life and IncellDx Partner to Develop Blood Tests to De-Risk Clinical Trials Relying on Tissue-Based BiomarkersEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
